Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.

about

Comparative effectiveness of the biosimilar CT-P13.

P2860

Q47418286-6056093A-17BA-4C1F-8C13-757571B210EE

P2860

Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.

Item

http://www.wikidata.org/entity/Q40314992

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Switching profiles in a popula ...... sults from the KOBIO registry.

@en

type

Item

label

Switching profiles in a popula ...... sults from the KOBIO registry.

@en

prefLabel

Switching profiles in a popula ...... sults from the KOBIO registry.

@en

P1476

Switching profiles in a popula ...... esults from the KOBIO registry

@en

P2093

Chan Hong Jeon

http://www.w3.org/2001/XMLSchema#string

Chang Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Dong-Jin Park

http://www.w3.org/2001/XMLSchema#string

Eon Jeong Nam

http://www.w3.org/2001/XMLSchema#string

Hyoun-Ah Kim

http://www.w3.org/2001/XMLSchema#string

Jaejoon Lee

http://www.w3.org/2001/XMLSchema#string

Kichul Shin

http://www.w3.org/2001/XMLSchema#string

Seong-Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Seung-Ki Kwok

http://www.w3.org/2001/XMLSchema#string

Shin-Seok Lee

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study.

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0.

Drug survival rates of tumor necrosis factor inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis.

Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

P304

1013-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-017-3584-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seong Wook Kang

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28243760

http://www.w3.org/2001/XMLSchema#string

Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.

about

P2860

P2860

Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698